News | January 24, 2007

New Stent Available for Carotid Interventions

Jan. 25, 2007 — ev3 Inc. has announced FDA approval of the PROTÉGÉ RX Carotid Stent, which, when used in conjunction with ev3’s SpideRX Embolic Protection Device, is indicated for the treatment of carotid artery disease in patients who are at high-risk for adverse events from carotid artery surgery.

The FDA approval was supported by the CREATE (Carotid Revascularization with ev3, Inc. Arterial Technology Evolution) Trial demonstrating the safety and effectiveness of the PROTÉGÉ stent in combination with the SPIDER Embolic Protection Device. Gary Ansel, M.D., Riverside Hospital, Columbus, Ohio, and Robert Safian, M.D., William Beaumont Hospital, Royal Oak, Mich.,
were the national co-principal investigators for the trial.

PROTÉGÉ RX is available in both straight and tapered stent configurations providing a variety of device options to address a broad range of patient anatomy present in carotid artery disease. The “rapid exchange” platform, the company says, allows for a single physician to operate the device as compared to “over the wire” designs that require multiple operators. The SpideRX Embolic Protection Device is the only available distal filter embolic protection device that permits physicians to use their guide wire of choice and is cleared by the FDA for use in both carotid arteries and saphenous vein grafts.

For further information, visit www.ev3.net.

Related Content

InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid| November 18, 2016
November 18, 2016 — InspireMD Inc.
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid| October 13, 2016
A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in...
CREST trial results, New England Journal of Medicine, stenting, endarterectomy, carotid artery stenosis
News | Cath Lab| March 04, 2016
Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are evidence that...
carotid artery stenting, outcomes, JACC, Beau Hawkins, Robert Yeh, CARE Registry
Feature | Stents Carotid| July 13, 2015
Hospitals performing carotid artery stenting vary considerably in rates of in-hospital stroke or death, according to a...
News | Stents Carotid| June 17, 2015
Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research,...
Technology | June 01, 2015
Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k) clearance for...
carotid artery stenting, F-EPD, P-EPD, ACC, embolic protection devices
News | April 22, 2015
A study published in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were...
VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results
Feature | November 11, 2014
Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announce clinical...
Stenting Safe Effective Long-term Stroke Prevention
News | October 16, 2014
Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal...
Overlay Init